Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccine in Radiologically Isolated Syndrome (RIS)
2018-000736-10Phase 2Active
- Sponsor
- Fondazione Italiana Sclerosi Multipla
- Start
- Oct 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of bcg vaccine in radiologically isolated syndrome (RIS), sponsored by Fondazione Italiana Sclerosi Multipla. Primary endpoint: Cumulative number of combined unique active lesions on MRI over 1 year. Started Oct 2020; status: active.
02
Drugs
bcg vaccine
03
Conditions
radiologically isolated syndrome (RIS)
Beyond the preview
Go deeper on 2018-000736-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000736-10.